Exicure Announces Webcast of Presentation at 2021 HC Wainwright BIOCONNECT Conference

Author's Avatar
Dec 29, 2020
Article's Main Image

Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced that David Giljohann, CEO, will present at the HC Wainwright Virtual BIOCONNECT Conference, January 11-14, 2021.